Adherence to Treatment with Selective Serotonin Reuptake Inhibitors and the Risk for Fractures and Bone Loss: A Population-Based Cohort Study
CNS Drugs, 06/08/2012
Clinical Article
Zucker I et al. – Exposure to Selective serotonin reuptake inhibitor (SSRI) treatment is associated with an increased risk of bone loss–related events.



